Well, one thing you can say about investing in biotechThere is never a dull moment for investorsOver the past six to nine months investing in the biotech sector has largely consisted of taking regular beatings interrupted occasionally by a temporary reprieveThis week has been no differentOn Monday, the SPDR S&P Biotech ETF (XBI) fell over 8% to hi...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.